The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

AI’s true power lies in pattern recognition across messy, real-world data: Natural language processing extracts phenotypes, comorbidities, and device usability feedback from unstructured clinical ...

Proactive documentation using AI reviews all patient data to reduce clinician burden and enhance care quality and efficiency.

In an industry where speed and precision can directly affect patient outcomes, pharma companies are under pressure to ...

Life sciences industry has regulatory compliance at the center of all its operations, so maintaining the integrity of data has always been a pressing need for this industry globally. Regulators such ...

Pharma’s finally catching up: real-time data is helping teams move faster, stay compliant and deliver better care where it counts. In the rapidly evolving pharmaceutical and healthcare landscape, ...

Data content management will drive the growing global data and analytics market in the pharmaceutical sector, which will reach a valuation of $2.1bn by 2028, according to a report. The 2024 edition of ...

The adoption of artificial intelligence (AI) has accelerated, yet its impact on R&D productivity remains underwhelming.

DUBLIN--(BUSINESS WIRE)--The "Efficient Batch Record Design and Review" training has been added to ResearchAndMarkets.com's offering. This online training is designed for professionals in the ...

When it comes to bringing life-saving therapeutics to market, the first significant investment for pharmaceutical companies is within research and development, which includes drug discovery, drug ...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that lacutamab, an anti-KIR3DL2 antibody, ...